116 related articles for article (PubMed ID: 22766023)
1. Diagnostic role of whole-body [18F]-FDG positron emission tomography in patients with symptoms suspicious for malignancy after heart transplantation.
Graute V; Jansen N; Sohn HY; Becker A; Klein B; Schmid I; Greil S; Lehner S; Bartenstein P; Pfluger T; Hacker M
J Heart Lung Transplant; 2012 Sep; 31(9):958-66. PubMed ID: 22766023
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of (18)FDG PET-CT scan as a diagnostic tool of fever of unknown origin].
García-Gómez FJ; Acevedo-Báñez I; Martínez-Castillo R; García-Gutiérrez M; Tirado-Hospital JL; Borrego-Dorado I
Med Clin (Barc); 2015 Jul; 145(2):62-6. PubMed ID: 25500351
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
4. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in evaluating non-CNS pediatric malignancies.
Tatsumi M; Miller JH; Wahl RL
J Nucl Med; 2007 Dec; 48(12):1923-31. PubMed ID: 18056332
[TBL] [Abstract][Full Text] [Related]
6. Fever of unknown origin: the role of 18F-FDG PET/CT.
Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
[TBL] [Abstract][Full Text] [Related]
7. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
[TBL] [Abstract][Full Text] [Related]
8. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
[TBL] [Abstract][Full Text] [Related]
9. The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.
Wareham NE; Lundgren JD; Da Cunha-Bang C; Gustafsson F; Iversen M; Johannesen HH; Kjær A; Rasmussen A; Sengeløv H; Sørensen SS; Fischer BM
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):421-431. PubMed ID: 27838763
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin.
Tokmak H; Ergonul O; Demirkol O; Cetiner M; Ferhanoglu B
Int J Infect Dis; 2014 Feb; 19():53-8. PubMed ID: 24295559
[TBL] [Abstract][Full Text] [Related]
11. Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging.
Ferda J; Ferdová E; Záhlava J; Matejovic M; Kreuzberg B
Eur J Radiol; 2010 Mar; 73(3):518-25. PubMed ID: 19201122
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
Kawata S; Imaizumi M; Kako Y; Oku N
Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
[TBL] [Abstract][Full Text] [Related]
13. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
[TBL] [Abstract][Full Text] [Related]
15. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
Yang J; Zhuang H
Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
[TBL] [Abstract][Full Text] [Related]
16. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
Mirpour S; Meteesatien P; Khandani AH
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):71-7. PubMed ID: 22088805
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG-PET/CT in fever of unknown origin: clinical value.
Buch-Olsen KM; Andersen RV; Hess S; Braad PE; Schifter S
Nucl Med Commun; 2014 Sep; 35(9):955-60. PubMed ID: 24801131
[TBL] [Abstract][Full Text] [Related]
18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
20. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
Clin Radiol; 2009 Jul; 64(7):675-81. PubMed ID: 19520211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
